Literature DB >> 33274509

Factors Affecting Contraception Access and Use in Patients With Opioid Use Disorder.

Rebecca H Stone1, Brooke Griffin2, Rachel A Fusco3, Kathy Vest2, Tran Tran2, Savannah Gross1.   

Abstract

Maternal opioid use disorder increased > 4-fold from 1999 to 2014 and is associated with poor maternal and fetal outcomes. Women with opioid use disorder are at 2 to 3 times greater risk for unintended pregnancy than the general population and may face additional barriers to accessing and effectively using contraception compared to women without opioid use disorder, particularly highly effective long-acting reversible contraception. Additionally, women with opioid use disorder tend to use less effective forms of contraception such as condoms alone. Barriers to contraceptive access include patient misconceptions or knowledge gaps regarding reproductive health and family planning, cost, intimate partner violence, fear of criminalization, difficulty accessing care, comorbid health conditions, and health care provider misconceptions or practice limitations. Strategies that may assist women with opioid use disorder in achieving their family planning goals include colocation of family planning services within opioid treatment facilities, optimization of patient care services to minimize the need for costly and/or time consuming follow-up, increasing provider education and awareness of best practices in family planning and opioid use disorder treatment, and providing patient-centered family planning education and counseling. Additional research is needed to identify and develop strategies that empower women who use opioids to effectively access and use their preferred contraceptive method.
© 2020, The American College of Clinical Pharmacology.

Entities:  

Keywords:  birth control; condom; contraception; family planning; neonatal abstinence syndrome; opioid use disorder; pregnancy; substance use disorder

Year:  2020        PMID: 33274509     DOI: 10.1002/jcph.1772

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  2 in total

1.  Ethical Issues in Providing and Promoting Contraception to Women with Opioid Use Disorder.

Authors:  Nadia Abbass; Tani Malhotra; Brooke Bullington
Journal:  J Clin Ethics       Date:  2022

2.  Contraception and Healthcare Utilization by Reproductive-Age Women Who Use Drugs in Rural Communities: a Cross-Sectional Survey.

Authors:  Ximena A Levander; Canyon A Foot; Sara L Magnusson; Ryan R Cook; Jerel M Ezell; Judith Feinberg; Vivian F Go; Kathryn E Lancaster; Elizabeth Salisbury-Afshar; Gordon S Smith; Ryan P Westergaard; April M Young; Judith I Tsui; P Todd Korthuis
Journal:  J Gen Intern Med       Date:  2022-06-15       Impact factor: 6.473

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.